TYMS POLYMORPHISMS AND METHOTREXATE THERAPEUTIC OUTCOME IN RHEUMATOID ARTHRITIS PORTUGUESE PATIENTS: ANALYSIS OF KEY POLYMORPHISMS

被引：0
|
作者：
Lima, A. [1 ,2 ,3 ]
Seabra, V. [1 ]
Bernardes, M. [4 ]
Azevedo, A. R. [5 ]
Sousa, H. [5 ]
Medeiros, R. [5 ]
机构：
[1] Gandra PRD, Inst Res & Adv Training Hlth Sci & Technol, Higher Inst Hlth Sci ISCS N, Dept Pharmaceut Sci,IINFACTS CESPU, Oporto, Portugal
[2] Univ Porto, Abel Salazar Inst Biomed Sci ICBAS, P-4100 Oporto, Portugal
[3] Portuguese Inst Oncol Porto IPO Porto, CI, Mol Oncol Grp, Oporto, Portugal
[4] Sao Joao Hosp Ctr, Rheumatol Dept, Oporto, Portugal
[5] Portuguese Inst Oncol Porto IPO Porto, Mol Oncol Grp CI, Oporto, Portugal
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.4672
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0457
引用
收藏
页码：341 / 341
页数：1
相关论文
共 50 条
  • [21] Genetic Polymorphisms in Metabolic and Cellular Transport Pathway of Methotrexate Impact Clinical Outcome of Methotrexate Monotherapy in Japanese Patients with Rheumatoid Arthritis
    Kato, Tomomi
    Hamada, Akinobu
    Mori, Shunsuke
    Saito, Hideyuki
    DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (02) : 192 - 199
  • [22] TYMS polymorphisms and responsiveness to or toxicity of methotrexate in rheumatoid arthritis; [TYMS-Polymorphismen und Empfindlichkeit gegenüber oder Toxizität von Methotrexat bei rheumatoider Arthritis]
    Bae S.-C.
    Lee Y.H.
    Zeitschrift für Rheumatologie, 2018, 77 (9) : 824 - 832
  • [23] Influence of methylenetetrahydrofolate reductase gene polymorphisms on methotrexate toxicity in patients with rheumatoid arthritis
    Tetik, A.
    Keser, G.
    Inal, V.
    Aksu, K.
    Eroglu, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 370 - 370
  • [24] Polymorphisms for the Clinical Efficacy and Toxicity of Methotrexate in Patients with Rheumatoid Arthritis: Systemic Review
    Alharthi, Ahlam
    Magadmi, Rania
    Jamal, Maha
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2024, 20 (04) : 547 - 551
  • [25] Polymorphisms predictive of outcomes of methotrexate therapy in rheumatoid arthritis are not transferable to patients with psoriasis
    Warren, R. B.
    Smith, R. L.
    Campalani, E.
    Smith, C. H.
    Barker, J. N.
    Worthington, J.
    Griffiths, C. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S55 - S55
  • [26] Comment on: Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate
    Kooloos, Wouter M.
    Guchelaar, Henk-Jan
    Huizinga, Tom W. J.
    Wessels, Judith A. M.
    RHEUMATOLOGY, 2009, 48 (09) : 1176 - 1177
  • [27] GENETIC POLYMORPHISMS IN KEY METHOTREXATE PATHWAY GENES ASSOCIATED WITH RESPONSE TO MTX TREATMENT IN RHEUMATOID ARTHRITIS
    Owen, Sally A.
    Eyre, Stephen
    Martin, Paul
    Hider, Samantha
    Bruce, Ian N.
    Barton, Anne
    Thomson, Wendy
    RHEUMATOLOGY, 2010, 49 : I5 - I5
  • [28] Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis
    Qiu, Qi
    Huang, Jing
    Shu, Xiaoming
    Fan, Huizheng
    Zhou, Youwen
    Xiao, Cheng
    SCIENTIFIC REPORTS, 2017, 7
  • [29] Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis
    Qi Qiu
    Jing Huang
    Xiaoming Shu
    Huizheng Fan
    Youwen Zhou
    Cheng Xiao
    Scientific Reports, 7
  • [30] Polymorphisms in Genes Involved in Methotrexate Pathway: Predictor of Response to Methotrexate Therapy in Indian Rheumatoid Arthritis Patients
    Singh, Ankita
    Nair, Harikrishnan
    Gupta, Vikas
    Sekhar, Pradeepta
    Misra, Ramnath
    Aggarwal, Amita
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345